Paints as a Scalable and Effective Radiative Cooling Technology for Buildings

Contributors

New Members of the Editorial Board and International Advisory Board of <i>Angewandte Chemie</i>

Authors

Notes on Contributors

<div class="authors authors-lg"><div class="author"><div class="author-img"><img src="https://cdn.insights.bio/uploads/Sood Pic copy.jpg" data-image="1"></div><div class="author-det"><h3 class="author-name" style="color:#5D538A;">Anil K Sood</h3><h5 class="author-title" style="color:#5D538A;">Professor, Department of Gynecologic Oncology and Reproductive Medicine, UT MD Anderson Cancer Center</h5> Dr Anil K Sood is Professor in the Department of Gynecologic Oncology and Reproductive Medicine at the UT MD Anderson Cancer Center. He holds a joint appointment in Cancer Biology and is co-director of the Center for RNA Interference and Non-Coding RNA at the M. D. Anderson Cancer Center. He is also Director of the multi-disciplinary Blanton-Davis Ovarian Cancer Research Program and co-leads the Ovarian Cancer Moonshot Program. Dr Sood received his medical degree from the University of North Carolina, Chapel Hill. A major and consistent theme of his scientific research has been on understanding human cancer biology and converting lab discoveries into novel therapeutics. His research group has made several seminal research contributions in the fields of tumor microenvironment, nanomedicine, and neuroendocrine effects on cancer biology. Dr Sood has received recognition for his research accomplishments including the Hunter Award, the Margaret Greenfield/Carmel Cohen Excellence in Ovarian Cancer Research Prize, and the GCF/Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher. He is an elected member of the American Society for Clinical Investigation (ASCI), the American Association for the Advancement of Science (AAAS), and the Association of American Physicians (AAP). Dr Sood was selected as an American Cancer Society Research Professor in 2017. </div></div></div><div class="authors authors-lg"><div class="author"><div class="author-img"><img src="https://cdn.insights.bio/uploads/Prabhakaran_Sandhya_1200x800 - Sandhya Prabhakaran copy.jpg" data-image="1"></div><div class="author-det"><h3 class="author-name" style="color:#00A795;"><strong>Sandhya Prabhakaran</strong></h3><h5 class="author-title" style="color:#00A795;">Applied Research Scientist, Integrated Mathematical Oncology Department, Moffitt Cancer Centre</h5> Dr. Sandhya Prabhakaran is an Applied Research Scientist at the Integrated Mathematical Oncology department, Moffitt Cancer Centre, Florida. Before that she was a Research Scientist at Memorial Sloan Kettering Cancer Centre and Columbia University. Her PhD in Computer Science is from University of Basel and her Masters in Intelligent Systems (Robotics) is from University of Edinburgh. Her research deals with developing statistical theory and Bayesian inference models, particularly to problems in Cancer Biology and Computer Vision. Prior to academics, she was an Assembler programmer working with the Mainframe Operating System (z/OS) at IBM Software Laboratories and has developed Mainframe applications. She has completed 4 out of the 6 World Marathon Majors. </div></div></div><div class="authors authors-lg"><div class="author"><div class="author-img"><strong><strong><strong><img src="https://cdn.insights.bio/uploads/Goldmacher photo.png" data-image="1"></strong></strong></strong></div><div class="author-det"><h3 class="author-name" style="color:#007589;"><strong><strong>Gregory Goldmacher</strong></strong></h3><h5 class="author-title" style="color:#007589;">Executive Director, Clinical Research, Head of Clinical Imaging, Merck Research Laboratories</h5> Greg has been at MSD since 2015. With his team of radiologists and imaging scientists, he oversees the clinical imaging in over 200 clinical trials in oncology and other therapeutic areas. He also leads research in radiomics, artificial intelligence, novel response criteria, tumor growth kinetics, and other innovative approaches to clinical trial imaging. Prior to MSD, he was a senior medical director and head of oncology imaging at a global CRO, and before that in academia. His clinical training was in diagnostic radiology, along with a PhD and postdoctoral work in neuroscience, and business training in finance. In his ‘free’ time, he enjoys playing with his kids, running, and training in the martial arts. </div></div><div class="author"><div class="author-img"><strong><strong><strong><img src="https://cdn.insights.bio/uploads/Sanjabi photo copy.png" data-image="1"></strong></strong></strong></div><div class="author-det"><h3 class="author-name" style="color: rgb(125, 203, 120);"><strong><strong>Shomyseh Sanjabi</strong></strong></h3><h5 class="author-title" style="color: rgb(125, 203, 120);">Principal Scientist, Oncology Biomarker Development, Genentech</h5> Shomyseh Sanjabi, PhD is a Principal Scientist in Oncology Biomarker Development (OBD) at Genentech. She obtained her bachelor’s degree in microbiology and molecular genetics from the University of California, Los Angeles (UCLA) and completed her PhD training with Dr Stephen Smale at UCLA in the department of microbiology, immunology, and molecular genetics elucidating the molecular mechanism of family member specificity among the NF-kappa-B family of transcription factors. She then completed a postdoctoral training in immunobiology at Yale University with Dr Richard Flavell studying the role of TGF-beta and common gamma chain cytokines in CD8 T cell development and function in the context of autoimmunity, anti-pathogen immunity, and cancer immunity. In 2010, she joined the faculty at the Gladstone Institute of Virology and Immunology and UCSF department of microbiology and immunology, where she was the recipient of numerous awards including an NIH New Innovator Award. Her independent academic research focused on using model pathogens and emerging human pathogens, together with preclinical genetic mouse models and human primary tissue samples to study how protective innate and adaptive immune responses are elicited and maintained upon mucosal transmission of viral pathogens. Her passion for human immunology and her vision to apply innovative technologies to study the immune response of patients undergoing cancer immunotherapy brought her to Genentech in 2018. She currently leads the biomarker and translational activities for several early-stage cancer immunotherapy programs. </div></div></div>

Current Opinion in Neurology was launched in 1988. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of neurology is divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Editors and Section Editors for this issue. EDITORS-IN-CHIEF Richard FrackowiakRichard FrackowiakRichard Frackowiak is Professor of Neurology and head of the new Department of Clinical Neurosciences at the Université de Lausanne in the Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland. His scientific interest is in human brain imaging with a focus on plasticity and structure-function relationships, especially in relation to neurodegenerative disease and genetic associations of cognition. He was previously Foundation Professor of Cognitive Neurology at University College London (UCL), UK, where he set up the Functional Imaging Laboratory (FIL), as a Wellcome Trust Principal Clinical Research Fellow. He has also directed the Institute of Neurology in Queen Square, UK, and the Department of Cognitive Studies at the Ecole Normale Supérieure in Paris, France. A Fellow of the Academies of Medical Sciences of the UK, France and Belgium, he is also a member of the Academia Europaea and of the Institute of Medicine of the American Academies. He advises the Director-General of INSERM and as honorary professor, the Provost & President of UCL. He is past-President of the British Neuroscience Association and currently presides over the European Brain and Behaviour Society. John MazziottaJohn MazziottaJohn Mazziotta has had a distinguished career of leadership, scientific achievement and service to the neuroscientific community. Scientifically, he has helped transform our understanding of diseases of the nervous system through the use of neuroimaging. These strategies and insights have greatly advanced our basic understanding of disease mechanisms, diagnostic criteria and the manner by which one can track conventional and experimental therapies. His basic science understanding of neuroimaging methods resulted in his having a leadership role in the development of methods that are now used on a global basis for acquiring and analyzing imaging data of the brain. These accomplishments include the development of both probabilistic and statistical mapping methods to analyze functional brain images. He, and others, then used these strategies to advance our understanding of normal brain function and its alteration in disease states. His contributions to the study of normal brain function include some of the first descriptions of the normal unstimulated brain's glucose metabolism in adults as well as the first, and currently only, study of glucose metabolism in the developing brain of children in the first decade of life. He and his University of California, Los Angeles (UCLA), USA, colleagues described the functional systems associated with normal vision (primary visual cortices, human visual motion center and shape analysis sites), auditory function, motor systems as well as brain networks that are critical to human learning and imitative behaviors. These studies of the normal human brain have now culminated in his establishment, as principal investigator, of the International Consortium for Brain Mapping (ICBM) involving eight laboratories, in seven countries, on four continents. The goal is to develop the first probabilistic atlas of the human brain including behavioral, demographic, imaging and genetic data from 7,000 subjects. This global effort will define the structural and functional variance of the human brain and will serve as a massive resource for exploring structure-function-genetic relationships in the normal human brain across all ages. When combined with probabilistic atlases of disease states, this system will provide a previously unavailable means for comparing investigations of normal and abnormal brain function, automated diagnoses and a quantitative, objective means of developing imaging biomarkers that will improve the efficacy of experimental clinical trials. Dr Mazziotta has had a leadership role in describing what has now become our understanding of the disruption of normal functional brain networks in a wide range of neurological disorders. These include the first papers describing the sites of altered metabolism or blood flow in the nervous system that occur even when brain structure remains intact. Publications by Dr Mazziotta and his UCLA colleagues describing these new observations have stood the test of time and include such disorders as epilepsy, depression, obsessive compulsive disorder, aphasias, movement disorders (tardive dyskinesia, Wilson's and Huntington's disease), migraine and Alzheimer's disease. Of note is the fact that Dr Mazziotta was the first to develop strategies for using both genetic risk profiles (Huntington's disease) and later specific genotypes to demonstrate the pattern of abnormal brain function that preceded clinical disease onset. This has now set the stage and provided the means by which to track and monitor presymptomatic individuals with disorders such as Huntington's and Alzheimer's disease, both to describe the natural history of the disorders, as well as to provide objective, noninvasive and quantifiable estimates of the efficacy of experimental therapies. Having had a strong leadership role in national societies and organizations as well as university governance, Dr Mazziotta established the first Brain Mapping Center at UCLA that included all of the methods available to study human brain structure and function. He is now the Chair of one of the largest neurology departments in the United States which last year achieved the distinguished position of being first in NIH research funding. As the chair of the Scientific Program Committee for the American Academy of Neurology, Dr Mazziotta transformed the program, invigorated its presentations and integrated basic and clinical neuroscience. This format and his innovations remain in place years after his influence began. As Editor-In-Chief of the journal NeuroImage, he and his co-editors took this fledgling publication to a position that dominates the field, with an impact factor that has been as high as nine in recent years. Adept at organizing and managing large national and international groups, he has been instrumental in organizing large symposia, consortia and task forces that have advanced both clinical and basic neuroscience. Since beginning this work, Dr Mazziotta has published more than 243 research papers and eight texts. He has received numerous awards and honors, including the Oldendorf Award from the American Society of Neuroimaging, the S. Weir Mitchell Award, the Wartenberg Prize of the American Academy of Neurology, the Von Hevesy Prize from the International Society of Nuclear Medicine, and the 1996 Medical Science Award from the UCLA Medical Alumni Association. Dr Mazziotta has been President and a founding member of the Institute for Clinical PET (positron emission tomography), the past chair of the Scientific Issues and Program Committee of the American Academy of Neurology, the past-President of the American Neuroimaging Society and the President of the Organization for Human Brain Mapping. Dr Mazziotta was elected to the prestigious Institute of Medicine of the National Academy of Sciences and the Royal College of Physicians. SECTION EDITORS Ralph L. SaccoRalph L. SaccoRalph L. Sacco has several positions at the Miller School of Medicine, University of Miami, USA. This includes the Chairman of Neurology, Olemberg Family Chair in Neurological Disorders, Miller Professor of Neurology, Public Health & Epidemiology, Neurosurgery and Human Genetics; and Executive Director of the Evelyn F. McKnight Brain Institute at the Miller School of Medicine. Finally, Dr Sacco is the Chief of the Neurology Service at the Jackson Memorial Hospital, USA. A graduate of Cornell University, USA and a cum laude graduate of Boston University School of Medicine, USA, he also holds a master's in epidemiology from Columbia University, School of Public Health, USA. Dr Sacco completed his neurology residency training and postdoctoral training in stroke and epidemiology at Columbia Presbyterian in New York, USA. He was previously Professor of Neurology, Chief of the Stroke and Critical Care Division, and Associate Chairman at Columbia University before taking his current position as Chairman of Neurology at the University of Miami, Miller School of Medicine, USA. Principal Investigator of the Northern Manhattan Study (NOMAS) and the Family Study of Carotid Atherosclerosis and Stroke Risk, as well as co-investigator of multiple other NIH grants, Dr Sacco has published extensively with nearly 400 peer-reviewed articles in the areas of stroke prevention, treatment, epidemiology, risk factors, human genetics, and stroke recurrence. He has been the recipient of numerous awards including, the Feinberg Award for Excellence in Clinical Stroke, the Chairman's Award from the American Heart Association, the NINDS Javits Award in Neuroscience, and the Wartenberg Lecture from the American Academy of Neurology. Dr Sacco is a fellow of both the Stroke and Epidemiology Councils of the American Heart Association and a former Board of Directors member of the American Academy of Neurology. He is a member of the American Association of Physicians and the American Neurological Association. He was the first neurologist to serve as President of the American Heart Association, from 2010 to 2011. Tatjana RundekTatjana RundekDr Tatjana Rundek is a Professor of Neurology, Vice Chair of Clinical Research, and a Director of Clinical Translational Research Division in the Department of Neurology of the University of Miami Miller School of Medicine, Miami, USA. Dr Rundek is a stroke neurologist, clinical researcher and principal investigator of several large longitudinal NIH funded projects on genetic determinants of carotid atherosclerosis and stroke epidemiology. Dr Rundek was the Fulbright Scholar and the recipient of the research awards from the Hazel K. Goddess and the Dr Gilbert Baum Fund and the American Institute in Ultrasound in Medicine for best clinical application of ultrasound. Her current research work is directed toward the genetic and environmental determinants of atherosclerosis, stroke, and use of ultrasound for early detection, intervention and prevention of functional and structural changes of arterial wall in inflammation. Dr Rundek serves on the editorial boards of several professional journals including Stroke, Neurology and Cerebrovascular Diseases. She is a member of the American Heart Association, American Academy of Neurology, and American Institute of Ultrasound in Medicine. She is currently President of the Neurosonology Community Practice of the American Institute of Ultrasound in Medicine, the largest professional medical ultrasound institution in the US. François-Xavier BorruatFrançois-Xavier BorruatFrançois-Xavier Borruat graduated from Lausanne Medical School, Switzerland, in 1980. He completed a two-year research fellowship at Bascom Palmer Eye Institute, Miami, USA, with Prof. S. G. Jacobson (Retinitis Pigmentosa Center) and obtained his MD thesis in 1990. Residency in ophthalmology was performed in Lausanne at the Hôpital Ophtalmique Jules-Gonin, Switzerland, where he worked later as Chief-Resident. François-Xavier Borruat pursued a clinical fellowship at The Institute of Neurology, The National Hospital, London, UK, with Prof. W. I. McDonald and Dr M. D. Sanders in 1991, and at Bascom Palmer Eye Institute, Miami with Prof. J. S. Glaser and Prof. N. J. Schatz in 1992. He was appointed as faculty member at the Hôpital Ophtalmique Jules-Gonin, Lausanne in 1994, where he has served since as the head of the Neuro-Ophthalmology Unit and Director of Resident Education. He received the academic titles of Privat-Docent (PD) in 2002 and Professeur Titulaire in 2012. He is an active member of several international societies, including the American Academy of Ophthalmology, North American Neuro-Ophthalmology Society, European Neuro-Ophthalmology Society, British Islands Neuro-Ophthalmology Club, and the Club de Neuro-Ophtalmologie Francophone. His work is mostly clinical with more than 100 publications in the field of neuro-ophthalmology and retinal disorders. Michael StruppMichael StruppMichael Strupp has been Professor of Neurology at the University of Munich, Germany, since 2003 and at the German Center for Vertigo and Balance Disorders (IFBLMU) since its inception in 2009. He studied medicine at the Technical University of Aachen, Germany, where he did his MD in the field of cardiophysiology. He then spent three years doing basic neuroscience research involving patch-clamp recordings with axons, muscle cells, glial cells and vestibular hair cells at the Department of Neurophysiology at the University of Munich, at Baylor College, Houston, USA, and at the Université de Montpellier, France. Prof. Strupp's particular areas of interest are the diagnosis and the therapy of vestibular, ocular motor and cerebellar disorders. He is one of the leading experts in this field, in which he has also developed a new therapeutic principle: the use of aminopyridines for the treatment of downbeat and upbeat nystagmus as well as episodic ataxia type 2 and cerebellar gait disorders. He is currently Joint-Chief-Editor of the Journal of Neurology and Editor-in-Chief of Frontiers in Neuro-Otology. He has received many clinical and scientific awards, including a “best teacher” award from the German Neurological Society, and has been a visiting professor at the University of Graz, Austria, and the University of Prague, Czech Republic. He is the author of more than 250 peer-reviewed papers and four text books on vertigo, dizziness and ocular motor disorders.

Contributors

Contributors

Contributors

Previous article FreeNotes on ContributorsCorrections to this articleErrataPDFPDF PLUSFull Text Add to favoritesDownload CitationTrack CitationsPermissionsReprints Share onFacebookTwitterLinked InRedditEmailQR Code SectionsMoreTina Adcock received her Ph.D. from the Scott Polar Research Institute at the University of Cambridge and is now a postdoctoral fellow at the Rutgers Center for Historical Analysis. She specializes in the history of science, exploration, and travel in the modern North American Arctic.Gerardo Aldana is Professor of Anthropology and [email protected] at the University of California, Santa Barbara. His interests broadly consider the sciences of ancient Mesoamerica but focus on the astronomy recorded in Mayan hieroglyphic texts. He is working on the historical contextualization of scientific discovery within the Dresden Codex Venus Table.Gerardo Aldana is Professor of Anthropology and [email protected] at UCSB. His interests broadly consider the sciences of ancient Mesoamerica, but focus on the astronomy recorded in Mayan hieroglyphic texts. He is currently working on the historical contextualization of scientific discovery within the Dresden Codex Venus Table.Brian Balmer is Professor of Science Policy Studies in the Department of Science and Technology Studies, University College London. His research interests combine historical and sociological approaches and include the history of chemical and biological warfare, the history of the “brain drain,” and the role of volunteers in biomedical research.Trevor Barnes is Professor of Geography at the University of British Columbia. His research interests are in the history of twentieth-century geographical thought.Richard H. Beyler teaches history of science, intellectual history, and German history at Portland State University in Oregon. His research focuses on the political history of scientific institutions in twentieth-century Germany and on the history of biophysics before the rise of molecular biology.Karin Bijsterveld, a historian, is a professor in the Department of Technology and Society Studies at Maastricht University. She is the coeditor (with Trevor Pinch) of The Oxford Handbook of Sound Studies (Oxford, 2012) and the author of Mechanical Sound: Technology, Culture, and Public Problems of Noise in the Twentieth Century (MIT, 2008).Francesca Bordogna is Associate Professor in the Program of Liberal Studies at the University of Notre Dame, where she is also a fellow of the Reilly Center for the History and Philosophy of Science. She is the author of William James at the Boundaries (Chicago, 2008) and is now working on a book on pragmatism in early twentieth-century Italy.Anastasios Brenner is Professor of Philosophy at the Université Paul Valéry—Montpellier 3. His research focuses on the history of philosophy of science, mainly on the French tradition, as well as the current relevance of historical epistemology. His most recent book is Raison scientifique et valeurs humaines (Presses Universitaires de France, 2011).Sonja Brentjes is a researcher at the Max Planck Institute for the History of Science in Berlin, Germany. Her areas of research are the history of science, cartography, and institutions and cross-cultural exchange of knowledge in Islamicate societies and the Mediterranean world (8th–17th centuries).John Hedley Brooke is Professor Emeritus of Science and Religion at Oxford University. He has published extensively on history of chemistry, Victorian science, and the historical relations between science and religion. His latest book, edited with Ronald Numbers, is Science and Religion around the World (Oxford, 2011).Mark B. Brown is a professor in the Department of Government at California State University, Sacramento. He is the author of Science in Democracy: Expertise, Institutions, and Representation (MIT Press, 2009), as well as various publications on the politics of expertise, citizen participation, bioethics, climate change, and related topics.Stephen T. Casper ([email protected]) is Assistant Professor in Humanities and Social Sciences at Clarkson University. His research focuses on the history of neurology, neuroscience, and physiology, topics on which he has published two books as well as several articles, essays, and reviews.Pratik Chakrabarti, Reader in History at the University of Kent, has published widely on history of science, medicine, and imperialism. His works include Materials and Medicine: Trade, Conquest, and Therapeutics in the Eighteenth Century and Bacteriology in British India: Laboratory Medicine and the Tropics. He is an editor of Social History of Medicine.Cristina Chimisso (http://www.open.ac.uk/Arts/philosophy/chimisso.shtml) is Senior Lecturer in European Studies and Philosophy at the Open University, United Kingdom. She is the author of Writing the History of the Mind: Philosophy and Science in France, 1900 to 1960s (Ashgate, 2008), and Gaston Bachelard: Critic of Science and the Imagination (Routledge, 2001).Deborah R. Coen is an associate professor of history at Barnard College, Columbia University, and the author, most recently, of The Earthquake Observers: Disaster Science from Lisbon to Richter (University of Chicago Press, 2013).Claudine Cohen, a philosopher and historian of earth and life sciences, holds professorships in science at the EPHE (Life and Earth Science Section) and in the humanities at the EHESS (Center for Language and Arts) in Paris. Her publications include Science, libertinage et clandestinité à l'aube des Lumières: Le transformisme de Telliamed (Presses Universitaires de France, 2011), La méthode de Zadig: La trace, le fossile, la preuve (Seuil, 2011), The Fate of the Mammoth: Fossils, Myths, and History (Chicago, 2002), and the first translation of Leibniz's Protogaea (with André Wakefield [Chicago, 2008]). In 2012 she was awarded the Eugen Wegmann Prize of the French Geological Society for her work in the history of geosciences.Roger Cooter is Honorary Professor in the Department of History at University College London. His latest book, Writing History in the Age of Biomedicine (Yale, 2013), was written with Claudia Stein. With her he is now working on a study of capitalism, biopolitics, and hygiene in Germany and Britain from the late nineteenth century.Andrew Ede is a historian of science specializing in history of chemistry. He is the Director of the Science, Technology, and Society Program and also teaches in the Department of History and Classics at the University of Alberta in Edmonton.Michael Egan (McMaster University) is the author of Barry Commoner and the Science of Survival: The Remaking of American Environmentalism (MIT Press, 2007). He is especially interested in the toxic century and is now at work on a global history of mercury pollution since World War II.Roger Emerson is Emeritus Professor of History at the University of Western Ontario, where he taught from 1964 to 1999. He is known for studies of the Scottish Enlightenment. His latest book, published in 2013, is a biography of an amateur scientist, improver, and politician: Archibald Campbell, third Duke of Argyll (1682–1761).Sterling Evans holds the Louise Welsh Chair in Southern Plains and Borderlands History at the University of Oklahoma. His research interests include environmental history, agricultural history, and borderlands history of North America and Latin America. He is the author of The Green Republic (1999) and Bound in Twine (2007).Paul Lawrence Farber is Oregon State University Distinguished Professor Emeritus. He does research on the history of natural history, racism, and evolution. His most recent book is Mixing Races: From Scientific Racism to Modern Evolutionary Ideas (2011).Steve Fuller holds the Auguste Comte Chair in Social Epistemology at the University of Warwick. He has authored more than twenty books, with two appearing in 2014: The Proactionary Imperative: A Foundation for Transhumanism (with Veronika Lipinska) and Knowledge: The Philosophical Quest in History.Alan Gabbey is Professor Emeritus of Philosophy, Barnard College, Columbia University. He is completing a book on Spinoza (Oxford University Press) and working on a book on mechanical philosophy in the early modern period.Cathy Gere is Associate Professor of History of Science at the University of California, San Diego. She is now working on a book about utilitarianism and the sciences of pain and pleasure.Pamela Gossin, Professor of History of Science and Literary Studies and the Director of Medical and Scientific Humanities at the University of Texas at Dallas, is writing two essays on nineteenth-century British literature and astronomy and creating a digital archive of the correspondence and scientific and literary essays of John G. Neihardt.Jean-Baptiste Gouyon is a science and technology scholar with a deep interest in the history of science in its public contexts. His research focuses on film, television, and museums as popular scientific media. He holds a Ph.D. in sociology from the University of York.Rich Hamerla is Associate Dean of the Honors College and Professor of the History of Science at the University of Oklahoma. In addition to his work in the history of chemistry, he teaches classes on Weapons of Mass Destruction and science and the Cold War and has publications addressing biological weapons.Darin Hayton is Associate Professor of the History of Science at Haverford College.John Henry is Professor of the History of Science at the University of Edinburgh. He recently published a collection of earlier research, Religion, Magic, and the Origins of Science in Early Modern England (Ashgate, 2012), and an introductory textbook, A Short History of Scientific Thought (Palgrave Macmillan, 2012).Noah Heringman is Professor of English at the University of Missouri. His publications include Romantic Rocks, Aesthetic Geology (2004) and Sciences of Antiquity: Romantic Antiquarianism, Natural History, and Knowledge Work (2013).Hunter Heyck is Associate Professor of the History of Science at the University of Oklahoma, where—much to his surprise—he has recently become department chair. His second book, The Age of System: The Rise and Fracture of High Modern Social Science, has just been accepted for publication by Johns Hopkins University Press.Jan P. Hogendijk is a professor of the history of mathematics in the Department of Mathematics at the University of Utrecht. His research interests are the history of the mathematical sciences in ancient Greek and medieval Islamic civilizations and the history of mathematics in the Netherlands between 1600 and 1850.Thierry Hoquet is Professor of Philosophy of Science in the Philosophy Faculty, University of Lyon 3, and a Junior Member of the Institut Universitaire de France. He specializes in the history of the life sciences, from Buffon to Darwin. He is currently completing a study on the way sex is variously defined by biologists.David A. Hounshell is Roderick Professor of Technology and Social Change at Carnegie Mellon University. He is the author of From the American System to Mass Production, 1800–1932 (1984), and “Planning and Executing ‘Automation’ at Ford Motor Company, 1945–1965: The Cleveland Engine Plant and Its Consequences,” in Fordism Transformed: The Development of Production Methods in the Automobile Industry, edited by Haruhito Shiomi and Kazuo Wada (Oxford, 1995).James Hull is an associate professor of history at the University of British Columbia (Kelowna) and an affiliate of the Institute for the History and Philosophy of Science and Technology (Toronto). He is Editor of Scientia Canadensis, the journal of the Canadian Science and Technology Historical Association.Georgia Irby is Associate Professor of Classical Studies at the College of William and Mary. Her research interests include the history of Greek and Roman science and the representation of science, broadly defined, in nonscientific Greco-Roman literature.Douglas M. Jesseph is Professor of Philosophy at the University of South Florida. He is the author of Berkeley's Philosophy of Mathematics, Squaring the Circle: The War between Hobbes and Wallis, and numerous articles on mathematics, methodology, and philosophy in the early modern period.Andrew Jewett is Associate Professor of History and of Social Studies at Harvard University and the author of Science, Democracy, and the American University: From the Civil War to the Cold War (Cambridge, 2012). He is currently a fellow at the National Humanities Center.Ann Johnson is an Associate Professor of History at the University of South Carolina. She works on the history of the physical sciences, engineering, technology, and modern Europe. Her most recent book was: Hitting the Brakes: Engineering Design and the Production of Knowledge (Duke, 2009)Paul Josephson teaches history at Colby College in Waterville, Maine, and is the author of the forthcoming Building a Soviet Arctic.Horst Kant studied physics, history, and philosophy of science. Since 1995 he has been a research scholar at the Max Planck Institute for the History of Science. His main subjects are history of physics in the nineteenth and twentieth centuries (especially institutional, social, and biographical aspects) and history of atomic physics.Peter P. Kirschenmann is Professor Emeritus in the Philosophy of the Natural Sciences and Philosophical Ethics at Vrije Universiteit, Amsterdam. He has worked on a great variety of philosophical topics; a selection of his published articles can be found in his Science, Nature, and Ethics: Critical Philosophical Studies (Delft: Eburon, 2001).W. R. Laird is Associate Professor of History at Carleton University, Ottawa, where he teaches medieval history and the history of science. He is the author of The Unfinished Mechanics of Giuseppe Moletti (Toronto, 2000) and coeditor (with Sophie Roux) of Mechanics and Natural Philosophy before the Scientific Revolution (Dordrecht, 2008).Christoph Lüthy directs the Center for the History of Philosophy and Science at Radboud University, Nijmegen. He is particularly interested in the history of natural philosophy and of scientific iconography. In 2012 he published David Gorlaeus (1591–1612): An Enigmatic Figure in the History of Philosophy and Science (Amsterdam University Press).Robert MacDougall is Associate Professor of History at the University of Western Ontario and the author of The People's Network: The Political Economy of the Telephone in the Gilded Age.Lisa Messeri is a postdoctoral fellow at the University of Pennsylvania. She holds a Ph.D. from MIT's Program in History, Anthropology, and Science, Technology, and Society. She is completing a manuscript entitled Placing Outer Space: An Earthly Ethnography of Other Worlds.Robert G. Morrison is Associate Professor of Religion at Bowdoin College. He is the author of Islam and Science: The Intellectual Career of Ni˙zām al-Dīn al-Nīsābūrī (Routledge, 2007).Stephanie Moser is Professor of Archaeology at the University of Southampton. She has published widely on the visual representation of archaeology and the portrayal and reception of the ancient world.Adriana Novoa is a cultural historian whose specialty is science in Latin America. She and Alex Levine have coauthored two books about Darwinism in Argentina (From Man to Monkey and Darwinistas!). Her articles have been published in the Journal of Latin American Studies in Context, the Latinoamericanist, Revista Hispánica Moderna, and elsewhere.Benjamin B. Olshin is Associate Professor of Philosophy, History of Science and Technology, and Design at the University of the Arts in Philadelphia. His research areas include the history of cartography and exploration, ancient science and engineering, the philosophy of contemporary physics, and traditional modes of knowledge transmission.John Parascandola taught at the University of Wisconsin–Madison before serving as Chief of the History of Medicine Division of the National Library of Medicine and as Public Health Service Historian. He is the author of The Development of American Pharmacology: John J. Abel and the Shaping of a Discipline.Valentina Pugliano is a Wellcome Trust Research Fellow in the Department of History and Philosophy of Science at the University of Cambridge and a Junior Research Fellow at Christ's College, Cambridge. Her work focuses on early modern artisanal practices and the interaction between medicine and science in the Republic of Venice and the Ottoman Levant.Nicky Reeves is a postdoctoral researcher at the Department of History and Philosophy of Science, University of Cambridge, where he is a member of the Arts and Humanities Research Council–funded project “The Board of Longitude, 1714–1828: Science, Innovation, and Empire in the Georgian World,” conducted in association with the National Maritime Museum, Greenwich.Raul Rojas is a professor of computer science in Berlin. He is the founder of the Konrad Zuse Internet Archive, the largest online source of documents and blueprints written or drafted by Konrad Zuse. He is the author of Die Rechenmaschinen von Konrad Zuse (Springer-Verlag, 1998).Nicolaas Rupke is Johnson Professor in the College at Washington and Lee University, having recently retired from the Chair of the History of Science at Göttingen. Among his books are Richard Owen: Biology without Darwin (Chicago, 2009) and Alexander von Humboldt: A Metabiography (Chicago, 2008). He is now working on the non-Darwinian tradition in evolutionary biology.Dr Juanita Feros Ruys is the Director of the University of Sydney Node of the ARC Centre of Excellence for the History of Emotions and is currently investigating Scholastic approaches to demonology. Her study of the late poetic works of Peter Abelard will be published by Palgrave in 2014.Tilman Sauer teaches history of science at the University of Bern and is a Senior Editor with the Einstein Papers Project at the California Institute of Technology, Pasadena.John Scarborough is Professor in the School of Pharmacy and the Departments of History and Classics (quondam) at the University of Wisconsin–Madison. His books include Roman Medicine (1969; 1976) and Pharmacy and Drug Lore in Antiquity: Greece, Rome, Byzantium (2010). He is coeditor (with Paul T. Keyser) of the Oxford Handbook of Science and Medicine in the Classical World (forthcoming).Andrew Scull is Distinguished Professor of Sociology and Science Studies at the University of California, San Diego. His recent books include Madness: A Very Short Introduction, Hysteria: The Disturbing History, and Durkheim and the Law (2nd ed.), with Steven Lukes.J.B. Shank is a graduate of Stanford University with a Ph.D. in European History and Humanities. He is currently completing a book entitled Before Voltaire: Newton, “Newtonianism,” and the Beginning of the French Enlightenment which is under contract with the University of Chicago Press.Ruth Lewin Sime is Emeritus Professor of Chemistry at Sacramento City College. She is the author of Lise Meitner: A Life in Physics and is now writing a biographical study of Otto Hahn.Daniel Lord Smail is a professor of history at Harvard University, where he works on deep human history and the history and anthropology of Mediterranean societies between 1100 and 1600. His current research approaches transformations in the material culture of later medieval Mediterranean Europe using household inventories and inventories of debt recovery from Lucca and Marseille.Vassiliki Betty Smocovitis is Professor of History of Science at the University of Florida. She is the author of Unifying Biology: The Evolutionary Synthesis and Evolutionary Biology. Her interests include the history of twentieth-century evolutionary biology, genetics, and systematics, and she has published extensively in the history of the botanical sciences in North America.Rudolf Werner Soukup, of the Technische Universität Vienna, works on alchemy and early chemistry, chemical research in the Habsburg Monarchy, and Robert Bunsen's library in Althofen. He is the author of Alchemistisches Gold, Paracelsistische Pharmaka (1997), Die wissenschaftliche Welt von gestern (2004), Chemie in Österreich (2007), and Pioniere der Sexualhormonforschung (2010).David Spanagel is an assistant professor of history at Worcester Polytechnic Institute. His first book (Johns Hopkins University Press, forthcoming) is a study of the political, material, and cultural contexts of geological ideas in New York State during the early nineteenth century, centering on Amos Eaton.Max Stadler is Chair for Science Studies at ETH Zurich. Professor Stadler works on the history of perception, the nervous system, technology and design. He has published extensively on the history of neuroscience.Larry Stewart is Professor of History and Director of the “Situating Science” node at the University of Saskatchewan. He is the author of The Rise of Public Science (1992) and, with Margaret Jacob, Practical Matter (2004), as well as various essays on the dissemination of scientific knowledge since Newton. He is now writing a study of experiment during the Enlightenment and the first industrial revolution and is editing, with Erica Dyck, a collection of essays on the use of humans in experiments.Heiko Stoff is Guest Professor for the History of Science and Technology at the Technical University of Braunschweig. He is the author of Ewige Jugend: Konzepte der Verjüngung vom späten 19. Jahrhundert bis ins Dritte Reich (Böhlau, 2004) and Wirkstoffe: Eine Wissenschaftsgeschichte der Hormone, Vitamine und Enzyme, 1920–1970 (Stuttgart, 2012).Bruno J. Strasser is a professor at the University of Geneva and an adjunct professor at Yale University. He is the author of a book on the history of molecular biology in postwar Europe, La fabrique d'une nouvelle science: La biologie moléculaire à l'age aomique, 1945–1964 (Florence, 2006). He is now finishing a book on the history of biomedical collections and databases.Laurence Totelin is a Wellcome Trust Research Fellow in the Department of History and Philosophy of Science at the University of Cambridge. Her publications include Hippocratic Recipes: Oral and Written Transmission of Pharmacological Recipes in Fifth- and Fourth-Century Greece (Brill, 2009).Janet Vertesi is Assistant Professor of Sociology at Princeton University. Her recent research examines NASA's robotic space exploration missions; her book, Seeing Like a in on the is forthcoming from the University of Chicago in is a Fellow at the University of Her publications include the book University Press, and several research on the to the of Her current project with the history of is a professor in the Department of History at the University of California, San Diego. His research is on the cultural history of early modern science, the and of His most recent book is The and is Professor of History and Philosophy at State College in New is Professor of Philosophy at the University of York and a of early modern and the reception of She is the author of at the Origins of (Oxford, and The World Previous article by of the History of Science Society by The History of Science Society. articles this

Contributors

Authors

Current Opinion in Obstetrics and Gynecology was launched in 1989. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of obstetrics and gynecology is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Editor and Section Editors for this issue. EDITOR Jonathan S. BerekJonathan S. BerekDr Berek is the Laurie Kraus Lacob Professor at Stanford, USA, where he is the Chair of the Department of Obstetrics and Gynecology, Stanford University School of Medicine, and the Director of the Stanford Women's Cancer Center at the Stanford Cancer Institute. Dr Berek is well known as a scholar, clinician, researcher and educator in the field. He is highly regarded for his research on the clinical management of gynecologic cancers and translational research related to these malignancies. He has published over 275 research papers, and many contributed articles, book chapters and monographs. He is especially noted for his popular books, Berek & Hacker's Gynecologic Oncology, in its 5th edition, and Berek & Novak's Gynecology, in it's 15th edition. Dr Berek earned his undergraduate degree from Brown, USA, his doctor of medicine degree at Johns Hopkins University School of Medicine, USA, completed his residency at Harvard Medical School, the Brigham and Women's Hospital, USA, and his fellowship in gynecologic oncology at the UCLA School of Medicine, USA. For many years, he was a Professor at UCLA, where he was also the Chair of the College of Applied Anatomy. Dr Berek is the Group Chair and Principal Investigator for the Cooperative Ovarian Cancer Group (COGI), which is a member of the Gynecologic Cancer Intergroup (GCIG). He was a Principal Investigator for the Gynecologic Oncology Group (GOG) for two decades. His primary research interest is in the immunology and immunotherapy of ovarian cancer, and through the development of experimental models and clinical trials, his initial studies encouraged the development of innovative biologic therapy strategies. Through collaborative work, his group focuses on the development of vaccines, monoclonal antibodies and targeted therapies for ovarian cancer. Dr Berek has had grant support from the National Institute of Health (NIH) and the Ovarian Cancer Research Foundation (OCRF). He is the recipient of the prestigious Sherman Mellinkoff Award and the Excellence in Education Award by the David Geffen School of Medicine at UCLA, and the 2010 John C. Fremont Pathfinder Award. He is regularly listed among America's Best Doctors for Gynecology & Gynecologic Oncology. He is board certified by the American Board of Obstetrics and Gynecology (ABOG), and the Division of Gynecologic Oncology. He is a Fellow in the American College of Obstetricians and Gynecologists (FACOG), the American College of Surgeons (FACS), and the American Society of Clinical Oncologists (FASCO). Dr Berek has served as an examiner for the American Board Obstetrics and Gynecology (ABOG) and for the Council on Resident Education in Obstetrics and Gynecology (CREOG). Dr Berek is the immediate Past-President of the Council of University Chairs of Obstetrics and Gynecology (CUCOG), and Past President of the International Gynecologic Cancer Society (IGCS). His many honors include receiving the President's Award from the Society of Gynecologic Oncologists (SGO), serving as its Vice President in 1996–1997, and presenting numerous distinguished lectureships. Dr Berek has served on many national committees for the National Institutes of Health (NIH), the National Cancer Institute (NCI), the American College of Surgeons (ACS), the Society of Gynecologic Oncologists (SGO), the American College of Obstetricians and Gynecologists (ACOG), and the American Society of Clinical Oncology (ASCO). He is a member of the Society of Gynecologic Investigation (SGI), and the Society of Pelvic Surgeons (SPS). He is the Editor in Chief of Current Problems in Obstetrics and Gynecology, ASCO Connections, and was a Senior Editor of the International Journal of Gynecologic Cancer. He has served as an Editor of Prolog and Précis for the American College of Obstetrics and Gynecology, and on the editorial boards of the Journal of Clinical Oncology, Gynecologic Oncology, and the Journal of the Society for Gynecologic Investigation. SECTION EDITORS Anne O. RodriguezAnne O. RodriguezDr Rodriguez received her medical and undergraduate degrees with honors at Northwestern University, USA, and completed her residency in Obstetrics and Gynecology at the University of North Carolina at Chapel Hill, USA. She then completed her fellowship in Gynecologic Oncology at the University of Miami/Jackson Memorial Hospital, USA. She served as Associate Professor and fellowship director of Gynecologic Oncology at the University of California, Davis, School of Medicine, USA and is now in active clinical practice in gynecologic oncology in Ventura and Santa Barbara, CA, with a special interest in fertility preservation in cancer patients. She is part of the teaching program in General Surgery at the Santa Barbara Cottage Hospital and is active in multiple research endeavors. She serves on the Core Planning Committee for the California Ovarian Cancer Awareness Program. Gottfried E. KonecnyGottfried E. KonecnyGottfried E. Konecny is Associate Professor of Medicine at the University of California Los Angeles (UCLA), USA. He is the lead clinician for gynecologic oncology in the Department of Medicine at UCLA. He obtained his medical degree and completed his residency training in obstetrics and gynecology at the University of Munich in Germany. Following his specialist training he focused on clinical breast cancer research and decided to move to the US to pursue postdoctoral studies in the laboratory of Dennis J. Slamon to participate in laboratory and clinical research that led to the approval of new breast cancer drugs such as trastuzumab and lapatinib, which target the specific genetic alteration of HER2 amplification found in about 25 percent of breast cancer patients. He subsequently undertook research and subspecialty training in gynecologic oncology by completing a gynecologic oncology fellowship at Mayo Clinic in Rochester Minnesota, USA. In 2007 he was recruited back to the University of California as a group leader to the Translational Oncology Research Laboratory of UCLA, to establish a laboratory for preclinical drug and clinical trial development in the area of gynecologic malignancies. His initiatives are primarily directed at using the latest and most effective technologies available to query breast, ovarian and endometrial cancer tissues, combined with appropriately characterized and molecularly defined preclinical models to identify new alterations and/or understand the role of known alterations in relevant genes and molecular pathways. His work primarily aims to identify physiologically distinct disease subgroups with their dominant signaling pathways and signaling alterations to develop subtype specific novel treatment approaches for patients diagnosed with breast, ovarian or endometrial cancer. As a physician-scientist his work focuses on translating the incredible revolution in our understanding of the molecular underpinnings of cancer into novel treatment approaches, in which each patient is treated according to the specific genetic alterations of the tumor. He currently serves as a member of the scientific program committee for the American Society of Clinical Oncology and has published his research findings in the likes of Cancer Research, Clinical Cancer Research, Journal of Clinical Oncology, Journal of the National Cancer Institute, Nature Genetics, Gynecologic Oncology and Breast Cancer Research and Treatment.

Stephen G. Young

About the Authors